Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …

Objetivo: determinar el significado que se ha dado al concepto de carga de la enfermedad
crónica no transmisible en pacientes, cuidadores familiares, profesionales del área de la …

AIM To determine the incidence of hepatocellular carcinoma (HCC) and the impact of HCC
surveillance on early diagnosis and survival of cirrhotic outpatients. METHODS In this …

In recent years, great progress has been made in the field of new therapeutic options for
hepatitis C virus (HCV) infection. The new direct-acting antiviral agents (DAAs) represent a …

Background Identifying patients with hepatitis C virus (HCV) infection and enhancing the
cascade of care are essential for eliminating HCV infection. This study aimed to estimate the …

Background Chronic hepatitis C is a major public health issue, but there is a gap in the
literature regarding the effectiveness and safety of direct-acting antiviral agents in the …

Introduction and objectives Glecaprevir/pibrentasvir is a highly effective and well tolerated
treatment for hepatitis C infection. Brazilian patients were not included in the original …

Background Liver-related mortality has been increasing worldwide. We aimed to estimate
the age-standardized mortality rates from viral hepatitis in Brazil. Methods The Brazilian …

Background: Hepatitis C is an important health problem. In Brazil, 1-2 million people are
infected. Despite this expressive number, and the availability of very successful treatment …

AIM To develop metabonomic models (MMs), using 1 H nuclear magnetic resonance (NMR)
spectra of serum, to predict significant liver fibrosis (SF: Metavir≥ F2), advanced liver …